Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-30T16:46:52.858Z Has data issue: false hasContentIssue false

Prevalence of hepatitis B infection markers in Lebanese children: the need for an expanded programme on immunization

Published online by Cambridge University Press:  30 May 2001

M. M. NABULSI
Affiliation:
Department of Pediatrics, American University of Beirut Medical Center, Beirut, Lebanon
G. F. ARAJ
Affiliation:
Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon
I. NUWAYHID
Affiliation:
Department of Environmental Health, American University of Beirut, Beirut, Lebanon
M. RAMADAN
Affiliation:
Department of Pediatrics, American University of Beirut Medical Center, Beirut, Lebanon
M. ARISS
Affiliation:
Department of Pediatrics, American University of Beirut Medical Center, Beirut, Lebanon
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

This multi-centre, cross-sectional study was designed to reveal the present status of hepatitis B infection markers among Lebanese children, and provide recommendations regarding childhood immunization policies. A total of 841 children, aged between 6 months and 6·5 years, were enrolled from Lebanon's five districts. Their sera were tested for hepatitis B surface antigen and hepatitis B core IgG. The overall prevalence of hepatitis B virus infection markers was 0·8 % with increasing age-specific rates from 0 % at 6 months to 1·3 % at > 5 years. There was no statistically significant association between the presence of hepatitis B markers and family characteristics or risk factors for infection. The highest prevalence rates were among children from Beirut suburbs (2·9 %) and South Lebanon (1·6 %). The risk of horizontal transmission of hepatitis B to uninfected children increased substantially after the age of 2 years. An expanded programme on immunization that integrates hepatitis B vaccine during the first year of life is needed.

Type
Research Article
Copyright
© 2001 Cambridge University Press